| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 6.60e-09 | 5 | 122 | 4 | GO:0010856 | |
| GeneOntologyMolecularFunction | calcium ion binding | FKBP10 FAT4 CALM1 CALM2 CALM3 PCDHGA7 FAT3 FSTL5 PCDHB6 DUOX2 DYSF PCDHB16 ITPR2 DUOX1 CDH22 PKD2L2 NKD2 PAM MAN1B1 | 1.41e-07 | 749 | 122 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 1.63e-07 | 9 | 122 | 4 | GO:0010854 | |
| GeneOntologyMolecularFunction | cyclase activator activity | 9.09e-07 | 13 | 122 | 4 | GO:0010853 | |
| GeneOntologyMolecularFunction | molecular tag activity | 1.27e-06 | 14 | 122 | 4 | GO:0141047 | |
| GeneOntologyMolecularFunction | titin binding | 1.27e-06 | 14 | 122 | 4 | GO:0031432 | |
| GeneOntologyMolecularFunction | protein tag activity | 1.27e-06 | 14 | 122 | 4 | GO:0031386 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 2.28e-06 | 16 | 122 | 4 | GO:0008179 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 3.80e-06 | 18 | 122 | 4 | GO:0010851 | |
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 4.39e-06 | 6 | 122 | 3 | GO:0031800 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 8.91e-06 | 22 | 122 | 4 | GO:0050998 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 1.26e-05 | 358 | 122 | 11 | GO:0044389 | |
| GeneOntologyMolecularFunction | RNA polymerase II core promoter sequence-specific DNA binding | 1.52e-05 | 25 | 122 | 4 | GO:0000979 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 2.14e-05 | 55 | 122 | 5 | GO:0001046 | |
| GeneOntologyMolecularFunction | kinase binding | RAF1 CEBPB CALM1 TTC28 CALM2 CALM3 BAG5 SREBF1 PFKM WNK1 PTK2 SCN5A IQSEC1 SYK PAM PARN PLCG2 FGR | 2.41e-05 | 969 | 122 | 18 | GO:0019900 |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 2.59e-05 | 10 | 122 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | NADH oxidase H202-forming activity | 3.70e-05 | 2 | 122 | 2 | GO:0106293 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 4.25e-05 | 337 | 122 | 10 | GO:0031625 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | COL5A1 SPTBN2 L1CAM OBSCN ITGA8 ITGA4 ITGAE PTK2 CDH22 CD47 SYK TNKS1BP1 CTTN | 7.71e-05 | 599 | 122 | 13 | GO:0050839 |
| GeneOntologyMolecularFunction | integrin binding | 1.01e-04 | 175 | 122 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 1.18e-04 | 16 | 122 | 3 | GO:0035256 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 1.36e-04 | 43 | 122 | 4 | GO:0043548 | |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 1.42e-04 | 17 | 122 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 2.35e-04 | 20 | 122 | 3 | GO:0019211 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 2.65e-04 | 93 | 122 | 5 | GO:0097110 | |
| GeneOntologyMolecularFunction | protein kinase binding | RAF1 CALM1 CALM2 CALM3 BAG5 SREBF1 WNK1 PTK2 SCN5A IQSEC1 SYK PAM PARN PLCG2 FGR | 2.83e-04 | 873 | 122 | 15 | GO:0019901 |
| GeneOntologyMolecularFunction | NADPH oxidase H202-forming activity | 3.66e-04 | 5 | 122 | 2 | GO:0106294 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 3.66e-04 | 5 | 122 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 5.85e-04 | 27 | 122 | 3 | GO:0001091 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | RAF1 POLE OBSCN TSSK2 FPGT PFKM WNK1 PTK2 GYS2 SELENOO SYK TAF1 CDK11B FGR TAF1L | 6.01e-04 | 938 | 122 | 15 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 6.50e-04 | 113 | 122 | 5 | GO:0019208 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 8.01e-04 | 30 | 122 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 8.83e-04 | 31 | 122 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | TBP-class protein binding | 1.06e-03 | 33 | 122 | 3 | GO:0017025 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CALM1 CALM2 CALM3 SPTBN2 EML6 OBSCN SYNPO DYSF PTK2 CEP350 NKD2 FGD4 SCN5A LIMCH1 CTTN FMNL1 | 1.07e-03 | 1099 | 122 | 16 | GO:0008092 |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 1.30e-03 | 9 | 122 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | NAD(P)H oxidase H2O2-forming activity | 2.35e-03 | 12 | 122 | 2 | GO:0016174 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 2.35e-03 | 12 | 122 | 2 | GO:0016175 | |
| GeneOntologyMolecularFunction | profilin binding | 2.76e-03 | 13 | 122 | 2 | GO:0005522 | |
| GeneOntologyMolecularFunction | calcium channel inhibitor activity | 2.76e-03 | 13 | 122 | 2 | GO:0019855 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 2.79e-03 | 46 | 122 | 3 | GO:0004715 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.98e-03 | 231 | 122 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 3.15e-03 | 48 | 122 | 3 | GO:0008200 | |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 3.31e-03 | 100 | 122 | 4 | GO:0019888 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 3.54e-03 | 50 | 122 | 3 | GO:0016248 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 3.74e-03 | 51 | 122 | 3 | GO:0141110 | |
| GeneOntologyMolecularFunction | phosphotyrosine residue binding | 3.74e-03 | 51 | 122 | 3 | GO:0001784 | |
| GeneOntologyMolecularFunction | protein kinase activity | 3.78e-03 | 600 | 122 | 10 | GO:0004672 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor activity | 3.95e-03 | 52 | 122 | 3 | GO:0016251 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 4.12e-03 | 172 | 122 | 5 | GO:0044325 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 4.14e-03 | 709 | 122 | 11 | GO:0016773 | |
| GeneOntologyMolecularFunction | myosin heavy chain binding | 4.74e-03 | 17 | 122 | 2 | GO:0032036 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 6.12e-03 | 446 | 122 | 8 | GO:0004674 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 6.55e-03 | 20 | 122 | 2 | GO:0050664 | |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 8.27e-08 | 8 | 123 | 4 | GO:1901842 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 2.07e-07 | 3 | 123 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | regulation of calcium-mediated signaling | 6.52e-07 | 121 | 123 | 8 | GO:0050848 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 7.86e-07 | 124 | 123 | 8 | GO:0007229 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 1.13e-06 | 228 | 123 | 10 | GO:0046777 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 1.21e-06 | 91 | 123 | 7 | GO:0033627 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 2.05e-06 | 5 | 123 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | regulation of high voltage-gated calcium channel activity | 2.07e-06 | 16 | 123 | 4 | GO:1901841 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | FAT4 PCDHGA7 FAT3 L1CAM PCDHB6 APOA1 ITGA4 WNK1 SLITRK1 PCDHB16 CDH22 | 2.81e-06 | 313 | 123 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 4.09e-06 | 6 | 123 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 4.09e-06 | 6 | 123 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | import into cell | CALM1 CALM2 CALM3 APOA1 ITGA4 DYSF WNK1 SLITRK1 PTK2 GPR107 RABEP1 SCN5A CD47 IQSEC1 SYK CACNA1I PLCG2 FGR CTTN SLC27A2 | 5.47e-06 | 1074 | 123 | 20 | GO:0098657 |
| GeneOntologyBiologicalProcess | negative regulation of voltage-gated calcium channel activity | 6.66e-06 | 21 | 123 | 4 | GO:1901386 | |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 1.69e-05 | 9 | 123 | 3 | GO:0060316 | |
| GeneOntologyBiologicalProcess | regulation of phagocytosis | 1.74e-05 | 136 | 123 | 7 | GO:0050764 | |
| GeneOntologyBiologicalProcess | positive regulation of protein autophosphorylation | 2.55e-05 | 29 | 123 | 4 | GO:0031954 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 3.15e-05 | 266 | 123 | 9 | GO:0019722 | |
| GeneOntologyBiologicalProcess | negative regulation of ryanodine-sensitive calcium-release channel activity | 3.30e-05 | 11 | 123 | 3 | GO:0060315 | |
| GeneOntologyBiologicalProcess | endocytosis | CALM1 CALM2 CALM3 APOA1 ITGA4 DYSF SLITRK1 PTK2 GPR107 RABEP1 CD47 IQSEC1 SYK PLCG2 FGR CTTN | 3.31e-05 | 827 | 123 | 16 | GO:0006897 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-threonine phosphorylation | 3.81e-05 | 32 | 123 | 4 | GO:0010800 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 4.38e-05 | 12 | 123 | 3 | GO:1990034 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling involved in cardiac conduction | 4.38e-05 | 12 | 123 | 3 | GO:1901844 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 5.16e-05 | 161 | 123 | 7 | GO:0051592 | |
| GeneOntologyBiologicalProcess | Fc receptor mediated stimulatory signaling pathway | 5.46e-05 | 35 | 123 | 4 | GO:0002431 | |
| GeneOntologyBiologicalProcess | detection of calcium ion | 5.67e-05 | 13 | 123 | 3 | GO:0005513 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 6.59e-05 | 115 | 123 | 6 | GO:0018107 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FAT4 CEBPB PCDHGA7 FAT3 L1CAM PCDHB6 SLFN12 ITGA8 APOA1 ITGA4 ITGAE WNK1 SLITRK1 PTK2 PCDHB16 CDH22 CD47 SYK | 7.00e-05 | 1077 | 123 | 18 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of voltage-gated calcium channel activity | 7.60e-05 | 38 | 123 | 4 | GO:1901385 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 8.43e-05 | 39 | 123 | 4 | GO:1901021 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transporter activity | 1.03e-04 | 41 | 123 | 4 | GO:1901020 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 1.05e-04 | 125 | 123 | 6 | GO:0018210 | |
| GeneOntologyBiologicalProcess | cuticle development | 1.05e-04 | 3 | 123 | 2 | GO:0042335 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.32e-04 | 187 | 123 | 7 | GO:0007156 | |
| GeneOntologyBiologicalProcess | negative regulation of release of sequestered calcium ion into cytosol | 1.32e-04 | 17 | 123 | 3 | GO:0051280 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling | 1.58e-04 | 18 | 123 | 3 | GO:0010649 | |
| GeneOntologyBiologicalProcess | regulation of protein autophosphorylation | 1.62e-04 | 46 | 123 | 4 | GO:0031952 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | RAF1 CALM1 CALM2 CALM3 BAG5 SLFN12 APOA1 CMYA5 DYSF WNK1 PTK2 CDCA2 UBB FGD4 SYK TNKS1BP1 LIMCH1 TAF1 PLCG2 FGR XRCC6 | 1.83e-04 | 1488 | 123 | 21 | GO:0031399 |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 1.87e-04 | 19 | 123 | 3 | GO:0051284 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by integrin | 1.87e-04 | 19 | 123 | 3 | GO:0033631 | |
| GeneOntologyBiologicalProcess | response to organophosphorus | 2.10e-04 | 142 | 123 | 6 | GO:0046683 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 2.19e-04 | 270 | 123 | 8 | GO:0007160 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transporter activity | 2.26e-04 | 92 | 123 | 5 | GO:1901019 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | RAF1 FKBP10 CALM1 CALM2 CALM3 SMC6 TSSK2 APOA1 WNK1 PTK2 SLF2 SYK TNKS1BP1 TAF1 PLCG2 FGR | 2.28e-04 | 976 | 123 | 16 | GO:0018193 |
| GeneOntologyBiologicalProcess | regulation of peptidyl-threonine phosphorylation | 2.61e-04 | 52 | 123 | 4 | GO:0010799 | |
| GeneOntologyBiologicalProcess | macrophage activation involved in immune response | 2.93e-04 | 22 | 123 | 3 | GO:0002281 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 2.93e-04 | 22 | 123 | 3 | GO:0010881 | |
| GeneOntologyBiologicalProcess | negative regulation of cation channel activity | 3.48e-04 | 56 | 123 | 4 | GO:2001258 | |
| GeneOntologyBiologicalProcess | positive regulation of cation channel activity | 3.48e-04 | 56 | 123 | 4 | GO:2001259 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 3.82e-04 | 24 | 123 | 3 | GO:0010801 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 4.25e-04 | 59 | 123 | 4 | GO:0086065 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 4.32e-04 | 25 | 123 | 3 | GO:0002433 | |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.32e-04 | 25 | 123 | 3 | GO:0038096 | |
| GeneOntologyBiologicalProcess | regulation of system process | CALM1 CALM2 CALM3 SREBF1 APOA1 ITGA4 CMYA5 WNK1 PTK2 ADORA3 SCN5A CTTN BEGAIN | 4.44e-04 | 734 | 123 | 13 | GO:0044057 |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 4.85e-04 | 166 | 123 | 6 | GO:0014074 | |
| GeneOntologyBiologicalProcess | regulation of ryanodine-sensitive calcium-release channel activity | 4.87e-04 | 26 | 123 | 3 | GO:0060314 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 4.87e-04 | 26 | 123 | 3 | GO:0086064 | |
| GeneOntologyBiologicalProcess | positive regulation of dephosphorylation | 5.14e-04 | 62 | 123 | 4 | GO:0035306 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 5.14e-04 | 62 | 123 | 4 | GO:0038093 | |
| GeneOntologyBiologicalProcess | positive regulation of mast cell degranulation | 5.45e-04 | 27 | 123 | 3 | GO:0043306 | |
| GeneOntologyBiologicalProcess | regulation of endocytosis | 5.47e-04 | 389 | 123 | 9 | GO:0030100 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 6.08e-04 | 28 | 123 | 3 | GO:0010882 | |
| GeneOntologyBiologicalProcess | positive regulation of regulated secretory pathway | 6.52e-04 | 66 | 123 | 4 | GO:1903307 | |
| GeneOntologyBiologicalProcess | heterotypic cell-cell adhesion | 6.52e-04 | 66 | 123 | 4 | GO:0034113 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte migration | 7.22e-04 | 179 | 123 | 6 | GO:0002687 | |
| GeneOntologyBiologicalProcess | tendon development | 7.26e-04 | 7 | 123 | 2 | GO:0035989 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 7.47e-04 | 30 | 123 | 3 | GO:0098901 | |
| GeneOntologyBiologicalProcess | positive regulation of actin filament bundle assembly | 7.72e-04 | 69 | 123 | 4 | GO:0032233 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transport | 7.72e-04 | 69 | 123 | 4 | GO:1903170 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 7.95e-04 | 410 | 123 | 9 | GO:0031589 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium-mediated signaling | 8.15e-04 | 70 | 123 | 4 | GO:0050850 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatase activity | 8.23e-04 | 31 | 123 | 3 | GO:0010922 | |
| GeneOntologyBiologicalProcess | myeloid cell activation involved in immune response | 9.22e-04 | 125 | 123 | 5 | GO:0002275 | |
| GeneOntologyBiologicalProcess | autophagosome membrane docking | 9.65e-04 | 8 | 123 | 2 | GO:0016240 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 9.91e-04 | 33 | 123 | 3 | GO:0010880 | |
| GeneOntologyBiologicalProcess | regulation of phosphatase activity | 1.00e-03 | 74 | 123 | 4 | GO:0010921 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | SPTBN2 OBSCN APOA1 SYNPO FGD4 CD47 IQSEC1 PAM LIMCH1 FGR ASB2 CTTN FMNL1 | 1.02e-03 | 803 | 123 | 13 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of dephosphorylation | 1.02e-03 | 128 | 123 | 5 | GO:0035303 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 1.06e-03 | 129 | 123 | 5 | GO:0002027 | |
| GeneOntologyBiologicalProcess | actin filament-based process | SPTBN2 OBSCN APOA1 SYNPO FGD4 SCN5A CD47 IQSEC1 PAM LIMCH1 FGR ASB2 CTTN FMNL1 | 1.09e-03 | 912 | 123 | 14 | GO:0030029 |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 1.18e-03 | 35 | 123 | 3 | GO:0010644 | |
| GeneOntologyBiologicalProcess | mitochondrion-endoplasmic reticulum membrane tethering | 1.24e-03 | 9 | 123 | 2 | GO:1990456 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | 1.26e-03 | 438 | 123 | 9 | GO:0032970 | |
| GeneOntologyBiologicalProcess | phagocytosis | 1.30e-03 | 274 | 123 | 7 | GO:0006909 | |
| GeneOntologyBiologicalProcess | action potential | 1.31e-03 | 201 | 123 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.39e-03 | 37 | 123 | 3 | GO:0014808 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 1.41e-03 | 81 | 123 | 4 | GO:0098900 | |
| GeneOntologyBiologicalProcess | regulation of cation channel activity | 1.43e-03 | 138 | 123 | 5 | GO:2001257 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte degranulation | 1.50e-03 | 38 | 123 | 3 | GO:0043302 | |
| GeneOntologyCellularComponent | myofibril | 5.81e-06 | 273 | 125 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 9.85e-06 | 290 | 125 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | TRAV12-2 CALM1 CALM2 CALM3 ITGA8 DUOX2 ITGA4 ITGAE DUOX1 CDH22 KCND1 SCN5A SYK CACNA1I C7 CTTN | 1.84e-05 | 785 | 125 | 16 | GO:0098797 |
| GeneOntologyCellularComponent | sarcomere | 1.92e-05 | 249 | 125 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.06e-04 | 384 | 125 | 10 | GO:0030139 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 2.18e-04 | 91 | 125 | 5 | GO:0008076 | |
| GeneOntologyCellularComponent | myelin sheath | 3.34e-04 | 217 | 125 | 7 | GO:0043209 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 3.51e-04 | 5 | 125 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | potassium channel complex | 4.04e-04 | 104 | 125 | 5 | GO:0034705 | |
| GeneOntologyCellularComponent | cation channel complex | 5.38e-04 | 235 | 125 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | spindle | 5.40e-04 | 471 | 125 | 10 | GO:0005819 | |
| GeneOntologyCellularComponent | sperm midpiece | 5.87e-04 | 64 | 125 | 4 | GO:0097225 | |
| GeneOntologyCellularComponent | growth cone | 6.88e-04 | 245 | 125 | 7 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 8.31e-04 | 253 | 125 | 7 | GO:0030427 | |
| GeneOntologyCellularComponent | presynapse | KCTD12 CALM1 CALM2 CALM3 SPTBN2 L1CAM RPS27A DYSF ADORA3 UBA52 RABEP1 CD47 IQSEC1 BEGAIN | 8.49e-04 | 886 | 125 | 14 | GO:0098793 |
| GeneOntologyCellularComponent | cell leading edge | 8.54e-04 | 500 | 125 | 10 | GO:0031252 | |
| GeneOntologyCellularComponent | integrin complex | 9.12e-04 | 32 | 125 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 9.28e-04 | 335 | 125 | 8 | GO:0061695 | |
| GeneOntologyCellularComponent | calcium channel complex | 9.64e-04 | 73 | 125 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | secretory vesicle | CALM1 CALM2 CALM3 SPTBN2 TSSK2 APOA1 DYSF ITPR2 KIAA1210 NKD2 VPS35L CD47 IQSEC1 PAM FGR XRCC6 SLC27A2 | 1.21e-03 | 1246 | 125 | 17 | GO:0099503 |
| GeneOntologyCellularComponent | Smc5-Smc6 complex | 1.24e-03 | 9 | 125 | 2 | GO:0030915 | |
| GeneOntologyCellularComponent | calyx of Held | 1.29e-03 | 36 | 125 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | spindle pole | 1.47e-03 | 205 | 125 | 6 | GO:0000922 | |
| GeneOntologyCellularComponent | spindle microtubule | 1.77e-03 | 86 | 125 | 4 | GO:0005876 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL5A1 COL11A1 CALM1 CALM2 CALM3 EML6 OBSCN SYNPO CMYA5 DYSF AKAP4 SCN5A TTL ASB2 CTTN ALPP | 1.79e-03 | 1179 | 125 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | COL5A1 COL11A1 CALM1 CALM2 CALM3 EML6 OBSCN SYNPO CMYA5 DYSF AKAP4 SCN5A TTL ASB2 CTTN ALPP | 1.92e-03 | 1187 | 125 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | Z disc | 2.15e-03 | 151 | 125 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 2.25e-03 | 12 | 125 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 2.25e-03 | 12 | 125 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | cytosolic small ribosomal subunit | 2.63e-03 | 46 | 125 | 3 | GO:0022627 | |
| GeneOntologyCellularComponent | transcription factor TFIID complex | 2.79e-03 | 47 | 125 | 3 | GO:0005669 | |
| GeneOntologyCellularComponent | exocytic vesicle | 3.16e-03 | 320 | 125 | 7 | GO:0070382 | |
| GeneOntologyCellularComponent | I band | 3.24e-03 | 166 | 125 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SPTBN2 L1CAM ITGA8 SYNPO SLITRK1 PTK2 RABEP1 CD47 IQSEC1 PARN CTTN BEGAIN | 3.64e-03 | 817 | 125 | 12 | GO:0098978 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 3.91e-03 | 107 | 125 | 4 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 3.91e-03 | 107 | 125 | 4 | GO:0001725 | |
| GeneOntologyCellularComponent | transport vesicle | 4.02e-03 | 519 | 125 | 9 | GO:0030133 | |
| GeneOntologyCellularComponent | mitotic spindle midzone | 4.03e-03 | 16 | 125 | 2 | GO:1990023 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 4.55e-03 | 17 | 125 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | CALM1 CALM2 CALM3 SREBF1 RPS27A DYSF ITPR2 UBA52 UBB UBC RABEP1 SBF2 VPS35L CD47 PAM SLC27A2 | 4.93e-03 | 1307 | 125 | 16 | GO:0030659 |
| GeneOntologyCellularComponent | NADPH oxidase complex | 5.10e-03 | 18 | 125 | 2 | GO:0043020 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 5.32e-03 | 59 | 125 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | actomyosin | 5.37e-03 | 117 | 125 | 4 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 5.53e-03 | 118 | 125 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | vesicle membrane | CALM1 CALM2 CALM3 SREBF1 RPS27A DYSF ITPR2 UBA52 UBB UBC RABEP1 SBF2 VPS35L CD47 PAM SLC27A2 | 5.62e-03 | 1325 | 125 | 16 | GO:0012506 |
| GeneOntologyCellularComponent | anchoring junction | SPTBN2 L1CAM OBSCN ITGA8 DUOX2 SYNPO ITGA4 PTK2 KIAA1210 CDH22 SCN5A TNKS1BP1 CTTN | 5.66e-03 | 976 | 125 | 13 | GO:0070161 |
| HumanPheno | Second degree atrioventricular block | 7.39e-06 | 15 | 46 | 4 | HP:0011706 | |
| HumanPheno | Abnormality of the peripheral nervous system | COL5A1 CALM1 CALM2 CALM3 L1CAM SREBF1 DUOX2 DYSF WNK1 NPHP3 SACS FGD4 SBF2 SETBP1 SCN5A VPS35L CEP19 | 1.22e-05 | 617 | 46 | 17 | HP:0410008 |
| HumanPheno | Abnormal cardiac exercise stress test | 2.04e-05 | 19 | 46 | 4 | HP:0500018 | |
| HumanPheno | Torsade de pointes | 6.41e-05 | 25 | 46 | 4 | HP:0001664 | |
| HumanPheno | Polymorphic ventricular tachycardia | 7.91e-05 | 10 | 46 | 3 | HP:0031677 | |
| HumanPheno | 2:1 atrioventricular block | 7.98e-05 | 2 | 46 | 2 | HP:0034305 | |
| HumanPheno | Prolonged QTc interval | 1.17e-04 | 29 | 46 | 4 | HP:0005184 | |
| HumanPheno | Sinus bradycardia | 1.34e-04 | 30 | 46 | 4 | HP:0001688 | |
| MousePheno | ventricular tachycardia | 4.26e-07 | 24 | 92 | 5 | MP:0008950 | |
| MousePheno | ventricular premature beat | 5.30e-07 | 25 | 92 | 5 | MP:0009732 | |
| MousePheno | increased heart rate | 1.38e-05 | 120 | 92 | 7 | MP:0002626 | |
| MousePheno | abnormal muscle fiber morphology | RAF1 CEBPB BAG5 OBSCN PFKM CMYA5 DYSF SACS SCN5A CD47 LIMCH1 | 7.04e-05 | 406 | 92 | 11 | MP:0004087 |
| MousePheno | sinus bradycardia | 9.53e-05 | 14 | 92 | 3 | MP:0010637 | |
| MousePheno | irregular heartbeat | 1.02e-04 | 71 | 92 | 5 | MP:0001636 | |
| Domain | Ubiquitin_CS | 3.42e-07 | 10 | 121 | 4 | IPR019954 | |
| Domain | Ubiquitin | 5.34e-07 | 11 | 121 | 4 | IPR019956 | |
| Domain | UBIQUITIN_1 | 3.88e-06 | 37 | 121 | 5 | PS00299 | |
| Domain | ubiquitin | 1.30e-05 | 47 | 121 | 5 | PF00240 | |
| Domain | UBIQUITIN_2 | 2.58e-05 | 54 | 121 | 5 | PS50053 | |
| Domain | Ubiquitin_dom | 3.66e-05 | 58 | 121 | 5 | IPR000626 | |
| Domain | TFIID_sub1_DUF3591 | 4.16e-05 | 2 | 121 | 2 | IPR022591 | |
| Domain | TBP-binding | 4.16e-05 | 2 | 121 | 2 | PF09247 | |
| Domain | DUOX1 | 4.16e-05 | 2 | 121 | 2 | IPR029595 | |
| Domain | DUF3591 | 4.16e-05 | 2 | 121 | 2 | PF12157 | |
| Domain | TAF_II_230-bd | 4.16e-05 | 2 | 121 | 2 | IPR009067 | |
| Domain | - | 4.16e-05 | 2 | 121 | 2 | 1.10.1100.10 | |
| Domain | TAF1_animal | 4.16e-05 | 2 | 121 | 2 | IPR011177 | |
| Domain | Integrin_alpha | 4.21e-05 | 11 | 121 | 3 | PF00357 | |
| Domain | Cadherin_CS | 7.67e-05 | 109 | 121 | 6 | IPR020894 | |
| Domain | ConA-like_dom | 9.09e-05 | 219 | 121 | 8 | IPR013320 | |
| Domain | CADHERIN_1 | 9.38e-05 | 113 | 121 | 6 | PS00232 | |
| Domain | Cadherin | 9.38e-05 | 113 | 121 | 6 | PF00028 | |
| Domain | BROMODOMAIN_1 | 9.38e-05 | 37 | 121 | 4 | PS00633 | |
| Domain | CADHERIN_2 | 9.84e-05 | 114 | 121 | 6 | PS50268 | |
| Domain | - | 9.84e-05 | 114 | 121 | 6 | 2.60.40.60 | |
| Domain | CA | 1.03e-04 | 115 | 121 | 6 | SM00112 | |
| Domain | Cadherin-like | 1.08e-04 | 116 | 121 | 6 | IPR015919 | |
| Domain | Cadherin | 1.19e-04 | 118 | 121 | 6 | IPR002126 | |
| Domain | Laminin_G_2 | 1.28e-04 | 40 | 121 | 4 | PF02210 | |
| Domain | Integrin_alpha_C_CS | 1.40e-04 | 16 | 121 | 3 | IPR018184 | |
| Domain | BROMODOMAIN_2 | 1.41e-04 | 41 | 121 | 4 | PS50014 | |
| Domain | Bromodomain | 1.55e-04 | 42 | 121 | 4 | IPR001487 | |
| Domain | BROMO | 1.55e-04 | 42 | 121 | 4 | SM00297 | |
| Domain | - | 1.55e-04 | 42 | 121 | 4 | 1.20.920.10 | |
| Domain | UBQ | 1.70e-04 | 43 | 121 | 4 | SM00213 | |
| Domain | LamG | 1.86e-04 | 44 | 121 | 4 | SM00282 | |
| Domain | Ubiquitin-rel_dom | 1.97e-04 | 184 | 121 | 7 | IPR029071 | |
| Domain | Integrin_alpha-2 | 2.02e-04 | 18 | 121 | 3 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 2.02e-04 | 18 | 121 | 3 | PS00242 | |
| Domain | Integrin_alpha2 | 2.02e-04 | 18 | 121 | 3 | PF08441 | |
| Domain | Integrin_alpha | 2.02e-04 | 18 | 121 | 3 | IPR000413 | |
| Domain | Int_alpha | 2.38e-04 | 19 | 121 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 2.38e-04 | 19 | 121 | 3 | IPR013519 | |
| Domain | TFIIA_a-hlx | 2.48e-04 | 4 | 121 | 2 | IPR009083 | |
| Domain | EF_HAND_1 | 3.69e-04 | 204 | 121 | 7 | PS00018 | |
| Domain | FG_GAP | 3.73e-04 | 22 | 121 | 3 | PS51470 | |
| Domain | - | 3.82e-04 | 95 | 121 | 5 | 2.60.120.200 | |
| Domain | PH | 4.59e-04 | 278 | 121 | 8 | SM00233 | |
| Domain | EF-hand_1 | 4.69e-04 | 152 | 121 | 6 | PF00036 | |
| Domain | PH_DOMAIN | 4.70e-04 | 279 | 121 | 8 | PS50003 | |
| Domain | PH_domain | 4.82e-04 | 280 | 121 | 8 | IPR001849 | |
| Domain | FG-GAP | 4.86e-04 | 24 | 121 | 3 | PF01839 | |
| Domain | FG-GAP | 4.86e-04 | 24 | 121 | 3 | IPR013517 | |
| Domain | Laminin_G | 5.43e-04 | 58 | 121 | 4 | IPR001791 | |
| Domain | Integrin_dom | 5.50e-04 | 25 | 121 | 3 | IPR032695 | |
| Domain | EF-hand-dom_pair | 5.67e-04 | 287 | 121 | 8 | IPR011992 | |
| Domain | Bromodomain_CS | 6.18e-04 | 26 | 121 | 3 | IPR018359 | |
| Domain | PH | 7.35e-04 | 229 | 121 | 7 | PF00169 | |
| Domain | EF_HAND_2 | 7.74e-04 | 231 | 121 | 7 | PS50222 | |
| Domain | EF_hand_dom | 7.94e-04 | 232 | 121 | 7 | IPR002048 | |
| Domain | RBD | 8.56e-04 | 7 | 121 | 2 | SM00455 | |
| Domain | NAD_binding_6 | 8.56e-04 | 7 | 121 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 8.56e-04 | 7 | 121 | 2 | PF08022 | |
| Domain | RBD_dom | 8.56e-04 | 7 | 121 | 2 | IPR003116 | |
| Domain | RBD | 8.56e-04 | 7 | 121 | 2 | PS50898 | |
| Domain | FAD-bd_8 | 8.56e-04 | 7 | 121 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 8.56e-04 | 7 | 121 | 2 | IPR013121 | |
| Domain | EF_Hand_1_Ca_BS | 9.81e-04 | 175 | 121 | 6 | IPR018247 | |
| Domain | An_peroxidase | 1.81e-03 | 10 | 121 | 2 | PF03098 | |
| Domain | Haem_peroxidase_animal | 1.81e-03 | 10 | 121 | 2 | IPR019791 | |
| Domain | Haem_peroxidase | 1.81e-03 | 10 | 121 | 2 | IPR010255 | |
| Domain | PEROXIDASE_3 | 1.81e-03 | 10 | 121 | 2 | PS50292 | |
| Domain | - | 1.81e-03 | 10 | 121 | 2 | 1.10.640.10 | |
| Domain | TPR_7 | 1.81e-03 | 10 | 121 | 2 | PF13176 | |
| Domain | PH_dom-like | 1.83e-03 | 426 | 121 | 9 | IPR011993 | |
| Domain | Bromodomain | 1.90e-03 | 38 | 121 | 3 | PF00439 | |
| Domain | LAM_G_DOMAIN | 1.90e-03 | 38 | 121 | 3 | PS50025 | |
| Domain | NC1_FIB | 2.20e-03 | 11 | 121 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 2.20e-03 | 11 | 121 | 2 | PD002078 | |
| Domain | Fib_collagen_C | 2.20e-03 | 11 | 121 | 2 | IPR000885 | |
| Domain | COLFI | 2.20e-03 | 11 | 121 | 2 | PF01410 | |
| Domain | COLFI | 2.20e-03 | 11 | 121 | 2 | SM00038 | |
| Domain | Cadherin_C | 2.53e-03 | 42 | 121 | 3 | IPR032455 | |
| Domain | Cadherin_C_2 | 2.53e-03 | 42 | 121 | 3 | PF16492 | |
| Domain | Ferric_reduct | 2.63e-03 | 12 | 121 | 2 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 2.63e-03 | 12 | 121 | 2 | IPR013130 | |
| Domain | uDENN | 3.60e-03 | 14 | 121 | 2 | SM00800 | |
| Domain | PROTEIN_KINASE_TYR | 3.65e-03 | 97 | 121 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 3.65e-03 | 97 | 121 | 4 | IPR008266 | |
| Domain | EFh | 3.68e-03 | 158 | 121 | 5 | SM00054 | |
| Domain | - | 3.96e-03 | 391 | 121 | 8 | 2.30.29.30 | |
| Domain | uDENN | 4.14e-03 | 15 | 121 | 2 | PF03456 | |
| Domain | TPR_2 | 4.16e-03 | 50 | 121 | 3 | PF07719 | |
| Domain | TPR_2 | 4.16e-03 | 50 | 121 | 3 | IPR013105 | |
| Domain | DENN | 4.71e-03 | 16 | 121 | 2 | SM00799 | |
| Domain | DENN | 4.71e-03 | 16 | 121 | 2 | PF02141 | |
| Domain | dDENN | 4.71e-03 | 16 | 121 | 2 | PF03455 | |
| Domain | AT_hook | 4.71e-03 | 16 | 121 | 2 | PF02178 | |
| Domain | UDENN | 4.71e-03 | 16 | 121 | 2 | PS50946 | |
| Domain | DDENN | 4.71e-03 | 16 | 121 | 2 | PS50947 | |
| Domain | dDENN | 4.71e-03 | 16 | 121 | 2 | SM00801 | |
| Domain | dDENN_dom | 4.71e-03 | 16 | 121 | 2 | IPR005112 | |
| Domain | uDENN_dom | 4.71e-03 | 16 | 121 | 2 | IPR005113 | |
| Domain | DENN | 4.71e-03 | 16 | 121 | 2 | PS50211 | |
| Pathway | REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC | 2.29e-09 | 4 | 99 | 4 | MM15591 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 5.75e-09 | 112 | 99 | 10 | MM15214 | |
| Pathway | KEGG_MEDICUS_REFERENCE_UCHL1_MEDIATED_HYDROLYSIS | 1.14e-08 | 5 | 99 | 4 | M49036 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 1.64e-08 | 25 | 99 | 6 | M27857 | |
| Pathway | REACTOME_RAS_PROCESSING | 2.48e-08 | 45 | 99 | 7 | MM15671 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 2.63e-08 | 131 | 99 | 10 | MM15717 | |
| Pathway | REACTOME_GLYCOGEN_SYNTHESIS | 2.94e-08 | 14 | 99 | 5 | M27247 | |
| Pathway | REACTOME_GLYCOGEN_STORAGE_DISEASES | 6.34e-08 | 16 | 99 | 5 | M27236 | |
| Pathway | REACTOME_FLT3_SIGNALING_BY_CBL_MUTANTS | 7.88e-08 | 7 | 99 | 4 | M41737 | |
| Pathway | REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS | 7.88e-08 | 7 | 99 | 4 | MM15593 | |
| Pathway | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | 7.88e-08 | 7 | 99 | 4 | MM15592 | |
| Pathway | REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM | 7.88e-08 | 7 | 99 | 4 | M29822 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 1.23e-07 | 18 | 99 | 5 | MM15680 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.23e-07 | 18 | 99 | 5 | MM14775 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 1.23e-07 | 18 | 99 | 5 | M47580 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 2.77e-07 | 93 | 99 | 8 | MM15204 | |
| Pathway | REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1 | 2.81e-07 | 9 | 99 | 4 | M27732 | |
| Pathway | REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS | 2.81e-07 | 9 | 99 | 4 | M27781 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING | 2.81e-07 | 9 | 99 | 4 | M26930 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_LOCALIZATION | 2.81e-07 | 9 | 99 | 4 | M27814 | |
| Pathway | REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1 | 2.81e-07 | 9 | 99 | 4 | MM14676 | |
| Pathway | REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION | 2.81e-07 | 9 | 99 | 4 | M29819 | |
| Pathway | REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA | 2.81e-07 | 9 | 99 | 4 | M27276 | |
| Pathway | REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1 | 2.81e-07 | 9 | 99 | 4 | MM15482 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING | 2.81e-07 | 9 | 99 | 4 | MM14535 | |
| Pathway | REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC | 2.87e-07 | 21 | 99 | 5 | M27875 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 2.87e-07 | 21 | 99 | 5 | MM15633 | |
| Pathway | REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER | 3.70e-07 | 22 | 99 | 5 | MM15303 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 3.70e-07 | 22 | 99 | 5 | MM15675 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 3.70e-07 | 22 | 99 | 5 | M903 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 3.84e-07 | 97 | 99 | 8 | M9400 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 4.19e-07 | 67 | 99 | 7 | MM15345 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 4.50e-07 | 99 | 99 | 8 | MM14910 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 4.65e-07 | 10 | 99 | 4 | MM14849 | |
| Pathway | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX | 4.65e-07 | 10 | 99 | 4 | MM15647 | |
| Pathway | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX | 4.65e-07 | 10 | 99 | 4 | M27925 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_LOCALIZATION | 4.65e-07 | 10 | 99 | 4 | MM15539 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 4.86e-07 | 100 | 99 | 8 | M27467 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 5.68e-07 | 70 | 99 | 7 | MM14824 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 5.89e-07 | 140 | 99 | 9 | M27484 | |
| Pathway | REACTOME_RAS_PROCESSING | 5.90e-07 | 24 | 99 | 5 | M38995 | |
| Pathway | REACTOME_REGULATION_OF_BACH1_ACTIVITY | 7.27e-07 | 11 | 99 | 4 | M41833 | |
| Pathway | REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX | 7.27e-07 | 11 | 99 | 4 | M27885 | |
| Pathway | REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY | 7.27e-07 | 11 | 99 | 4 | MM15668 | |
| Pathway | REACTOME_PEXOPHAGY | 7.27e-07 | 11 | 99 | 4 | MM15673 | |
| Pathway | REACTOME_REGULATION_OF_BACH1_ACTIVITY | 7.27e-07 | 11 | 99 | 4 | MM15686 | |
| Pathway | REACTOME_REGULATION_OF_TBK1_IKK_MEDIATED_ACTIVATION_OF_IRF3_IRF7_UPON_TLR3_LIGATION | 7.27e-07 | 11 | 99 | 4 | M48241 | |
| Pathway | REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY | 7.27e-07 | 11 | 99 | 4 | M29827 | |
| Pathway | REACTOME_PEXOPHAGY | 7.27e-07 | 11 | 99 | 4 | M29846 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 7.33e-07 | 25 | 99 | 5 | M41829 | |
| Pathway | REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER | 7.33e-07 | 25 | 99 | 5 | M27593 | |
| Pathway | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | 9.03e-07 | 26 | 99 | 5 | M907 | |
| Pathway | WP_COVID19_STRUCTURAL_COVERAGE_MAP | 9.03e-07 | 26 | 99 | 5 | M48318 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 1.00e-06 | 76 | 99 | 7 | M19832 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 1.05e-06 | 150 | 99 | 9 | MM14889 | |
| Pathway | REACTOME_JOSEPHIN_DOMAIN_DUBS | 1.08e-06 | 12 | 99 | 4 | M27577 | |
| Pathway | REACTOME_JOSEPHIN_DOMAIN_DUBS | 1.08e-06 | 12 | 99 | 4 | MM15288 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 1.08e-06 | 12 | 99 | 4 | MM14550 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | 1.09e-06 | 77 | 99 | 7 | MM14513 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.30e-06 | 79 | 99 | 7 | M27643 | |
| Pathway | REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES | 1.56e-06 | 13 | 99 | 4 | MM14827 | |
| Pathway | REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL | 1.56e-06 | 13 | 99 | 4 | MM14828 | |
| Pathway | REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION | 1.56e-06 | 13 | 99 | 4 | MM15280 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 1.56e-06 | 13 | 99 | 4 | M549 | |
| Pathway | REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES | 1.56e-06 | 13 | 99 | 4 | M14582 | |
| Pathway | REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7 | 1.56e-06 | 13 | 99 | 4 | M27884 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | 1.56e-06 | 13 | 99 | 4 | M967 | |
| Pathway | REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION | 1.56e-06 | 13 | 99 | 4 | M29823 | |
| Pathway | REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA | 1.56e-06 | 13 | 99 | 4 | MM14931 | |
| Pathway | REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL | 1.56e-06 | 13 | 99 | 4 | M736 | |
| Pathway | REACTOME_FLT3_SIGNALING | 1.60e-06 | 29 | 99 | 5 | MM15652 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 1.91e-06 | 30 | 99 | 5 | M41825 | |
| Pathway | REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX | 1.91e-06 | 30 | 99 | 5 | MM14476 | |
| Pathway | REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX | 1.91e-06 | 30 | 99 | 5 | M26898 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 2.15e-06 | 85 | 99 | 7 | MM14746 | |
| Pathway | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | 2.17e-06 | 14 | 99 | 4 | MM14826 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.17e-06 | 14 | 99 | 4 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.17e-06 | 14 | 99 | 4 | M47388 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FLT3 | 2.17e-06 | 14 | 99 | 4 | MM15682 | |
| Pathway | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | 2.17e-06 | 14 | 99 | 4 | M935 | |
| Pathway | REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING | 2.17e-06 | 14 | 99 | 4 | MM15642 | |
| Pathway | REACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7 | 2.17e-06 | 14 | 99 | 4 | M48239 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR | 2.17e-06 | 14 | 99 | 4 | M47975 | |
| Pathway | REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS | 2.27e-06 | 31 | 99 | 5 | M46423 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 2.67e-06 | 32 | 99 | 5 | MM1355 | |
| Pathway | REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS | 2.67e-06 | 32 | 99 | 5 | M27538 | |
| Pathway | REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS | 2.67e-06 | 32 | 99 | 5 | MM15260 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 2.94e-06 | 15 | 99 | 4 | M47385 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | 2.94e-06 | 15 | 99 | 4 | MM14875 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FLT3 | 2.94e-06 | 15 | 99 | 4 | M41735 | |
| Pathway | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | 2.94e-06 | 15 | 99 | 4 | MM15175 | |
| Pathway | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | 2.94e-06 | 15 | 99 | 4 | MM15645 | |
| Pathway | REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL | 2.94e-06 | 15 | 99 | 4 | M27774 | |
| Pathway | REACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7 | 2.94e-06 | 15 | 99 | 4 | MM17228 | |
| Pathway | REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA | 2.94e-06 | 15 | 99 | 4 | M27229 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 2.94e-06 | 15 | 99 | 4 | M27202 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 3.13e-06 | 33 | 99 | 5 | M9494 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 3.13e-06 | 33 | 99 | 5 | M604 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 3.33e-06 | 5 | 99 | 3 | MM14493 | |
| Pathway | REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM | 3.65e-06 | 34 | 99 | 5 | M27546 | |
| Pubmed | DENND4A HIVEP1 OBSCN CMYA5 DYSF WNK1 ANKRD46 UBB UBC NPHP3 UPF2 ADAMTS9 RABEP1 TAF1 ZNF417 XRCC6 | 3.56e-11 | 497 | 125 | 16 | 23414517 | |
| Pubmed | 1.59e-10 | 4 | 125 | 4 | 21167176 | ||
| Pubmed | A calcium sensor in the sodium channel modulates cardiac excitability. | 1.59e-10 | 4 | 125 | 4 | 11807557 | |
| Pubmed | 1.59e-10 | 4 | 125 | 4 | 16505387 | ||
| Pubmed | 3.11e-10 | 46 | 125 | 7 | 19190083 | ||
| Pubmed | 7.93e-10 | 5 | 125 | 4 | 25232683 | ||
| Pubmed | 7.93e-10 | 5 | 125 | 4 | 22705208 | ||
| Pubmed | 7.93e-10 | 5 | 125 | 4 | 21436055 | ||
| Pubmed | Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). | 2.16e-09 | 60 | 125 | 7 | 12787561 | |
| Pubmed | 3.17e-08 | 134 | 125 | 8 | 24658140 | ||
| Pubmed | 3.28e-08 | 10 | 125 | 4 | 15143060 | ||
| Pubmed | HSJ1 is a neuronal shuttling factor for the sorting of chaperone clients to the proteasome. | 3.28e-08 | 10 | 125 | 4 | 15936278 | |
| Pubmed | 3.28e-08 | 10 | 125 | 4 | 10882101 | ||
| Pubmed | Phosphorylation of Pirh2 by calmodulin-dependent kinase II impairs its ability to ubiquitinate p53. | 3.28e-08 | 10 | 125 | 4 | 17568776 | |
| Pubmed | The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. | 3.28e-08 | 10 | 125 | 4 | 11231585 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 29932249 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 18370588 | ||
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 4.53e-08 | 3 | 125 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 4.53e-08 | 3 | 125 | 3 | 9923700 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 9681195 | ||
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 4.53e-08 | 3 | 125 | 3 | 23893133 | |
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 4.53e-08 | 3 | 125 | 3 | 8573130 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 10899953 | ||
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 4.53e-08 | 3 | 125 | 3 | 9278050 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 15719022 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 4.53e-08 | 3 | 125 | 3 | 11847276 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 10416864 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 7828884 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 8862395 | ||
| Pubmed | Crystallographic basis for calcium regulation of sodium channels. | 4.53e-08 | 3 | 125 | 3 | 22331908 | |
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 4.53e-08 | 3 | 125 | 3 | 2469574 | |
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 4.53e-08 | 3 | 125 | 3 | 15632291 | |
| Pubmed | Blocking the Ca2+-induced conformational transitions in calmodulin with disulfide bonds. | 4.53e-08 | 3 | 125 | 3 | 8631777 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 18553937 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 14978283 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 11988077 | ||
| Pubmed | Calmodulin and HIV type 1: interactions with Gag and Gag products. | 4.53e-08 | 3 | 125 | 3 | 11054265 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 33191766 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 18940602 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 25268113 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 19651602 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 26969752 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 32751694 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 8314583 | ||
| Pubmed | Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. | 4.53e-08 | 3 | 125 | 3 | 11807546 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 8312049 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 37380439 | ||
| Pubmed | Structure of tetraubiquitin shows how multiubiquitin chains can be formed. | 4.53e-08 | 3 | 125 | 3 | 8107144 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 31628181 | ||
| Pubmed | Sequence homology of the 3'-untranslated region of calmodulin III in mammals. | 4.53e-08 | 3 | 125 | 3 | 11710561 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 2445749 | ||
| Pubmed | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. | 4.53e-08 | 3 | 125 | 3 | 9362478 | |
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 4.53e-08 | 3 | 125 | 3 | 3384819 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 21799007 | ||
| Pubmed | Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. | 4.53e-08 | 3 | 125 | 3 | 20956522 | |
| Pubmed | Calmodulin controls liver proliferation via interactions with C/EBPbeta-LAP and C/EBPbeta-LIP. | 4.53e-08 | 3 | 125 | 3 | 20498378 | |
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 4.53e-08 | 3 | 125 | 3 | 18786401 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 11072229 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 16229872 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 15063758 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 8226798 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 1321656 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 9658102 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 4.53e-08 | 3 | 125 | 3 | 17582331 | |
| Pubmed | A calmodulin-binding sequence in the C-terminus of human cardiac titin kinase. | 1.81e-07 | 4 | 125 | 3 | 7607248 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 27516456 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 30842726 | ||
| Pubmed | Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. | 1.81e-07 | 4 | 125 | 3 | 23040497 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 16299511 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 25437912 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 17046994 | ||
| Pubmed | A network of control mediated by regulator of calcium/calmodulin-dependent signaling. | 1.81e-07 | 4 | 125 | 3 | 15499021 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 10692436 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 16478480 | ||
| Pubmed | Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. | 1.81e-07 | 4 | 125 | 3 | 16127172 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 20226167 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 10823944 | ||
| Pubmed | Calm1 signaling pathway is essential for the migration of mouse precerebellar neurons. | 1.81e-07 | 4 | 125 | 3 | 25519244 | |
| Pubmed | Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. | 1.81e-07 | 4 | 125 | 3 | 14960328 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 22405011 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 11736632 | ||
| Pubmed | Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. | 1.81e-07 | 4 | 125 | 3 | 29724949 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 11286509 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 20953164 | ||
| Pubmed | Regulation of follitropin receptor cell surface residency by the ubiquitin-proteasome pathway. | 1.81e-07 | 4 | 125 | 3 | 12960054 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 19855925 | ||
| Pubmed | Calmodulin binding to the Fas death domain. Regulation by Fas activation. | 1.81e-07 | 4 | 125 | 3 | 14594800 | |
| Pubmed | Structure of calmodulin bound to the hydrophobic IQ domain of the cardiac Ca(v)1.2 calcium channel. | 1.81e-07 | 4 | 125 | 3 | 16338416 | |
| Pubmed | Role of calmodulin in HIV-potentiated Fas-mediated apoptosis. | 1.81e-07 | 4 | 125 | 3 | 8780394 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 19279214 | ||
| Pubmed | Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis. | 1.81e-07 | 4 | 125 | 3 | 10625668 | |
| Pubmed | Molecular basis of the death-associated protein kinase-calcium/calmodulin regulator complex. | 1.81e-07 | 4 | 125 | 3 | 20103772 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 9096366 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 12577052 | ||
| Pubmed | FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. | 1.81e-07 | 4 | 125 | 3 | 22067155 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 11448995 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 25441029 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 26164367 | ||
| Pubmed | RAF1 KCTD12 COL5A1 SPTBN2 BAG5 SYNPO RPS27A IDH2 PFKM ITPR2 HNRNPUL2 VPS35L SNRNP40 TNKS1BP1 LIMCH1 CTTN TIMM44 XRCC6 SLC27A2 ALPP | 2.18e-07 | 1440 | 125 | 20 | 30833792 | |
| Pubmed | 2.80e-07 | 16 | 125 | 4 | 15721744 | ||
| Interaction | MYH9 interactions | RAF1 DENND4A HIVEP1 CEBPB CALM1 SPTBN2 BAG5 SYNPO ITGA4 WNK1 ITPR2 RNF123 UBC HNRNPUL2 TNKS1BP1 LIMCH1 CTTN XRCC6 | 7.44e-07 | 754 | 123 | 18 | int:MYH9 |
| Interaction | ESCO1 interactions | 9.84e-07 | 30 | 123 | 5 | int:ESCO1 | |
| Interaction | NSMF interactions | 2.19e-06 | 35 | 123 | 5 | int:NSMF | |
| Interaction | MMEL1 interactions | 2.20e-06 | 5 | 123 | 3 | int:MMEL1 | |
| Interaction | PFN1 interactions | RAF1 CEBPB CALM1 ITGA4 WNK1 CEP350 UBB RNF123 RABEP1 TNKS1BP1 LIMCH1 ASB2 FMNL1 XRCC6 | 2.80e-06 | 509 | 123 | 14 | int:PFN1 |
| Interaction | MYO1E interactions | 4.20e-06 | 202 | 123 | 9 | int:MYO1E | |
| Interaction | RABGEF1 interactions | 4.55e-06 | 204 | 123 | 9 | int:RABGEF1 | |
| Interaction | IQSEC2 interactions | 7.01e-06 | 44 | 123 | 5 | int:IQSEC2 | |
| Interaction | SPATA17 interactions | 7.63e-06 | 7 | 123 | 3 | int:SPATA17 | |
| Interaction | UBE3B interactions | 9.75e-06 | 47 | 123 | 5 | int:UBE3B | |
| Interaction | SH3BP2 interactions | 1.08e-05 | 48 | 123 | 5 | int:SH3BP2 | |
| Interaction | KCNN1 interactions | 1.21e-05 | 8 | 123 | 3 | int:KCNN1 | |
| Interaction | ARPP21 interactions | 1.21e-05 | 8 | 123 | 3 | int:ARPP21 | |
| Interaction | UNC13B interactions | 1.61e-05 | 52 | 123 | 5 | int:UNC13B | |
| Interaction | LOC102724334 interactions | 1.84e-05 | 134 | 123 | 7 | int:LOC102724334 | |
| Interaction | SYK interactions | 2.39e-05 | 251 | 123 | 9 | int:SYK | |
| Interaction | IQCG interactions | 2.58e-05 | 10 | 123 | 3 | int:IQCG | |
| Interaction | H2BC15 interactions | 2.92e-05 | 144 | 123 | 7 | int:H2BC15 | |
| Interaction | HERC2P9 interactions | 3.20e-05 | 30 | 123 | 4 | int:HERC2P9 | |
| Interaction | H2BC5 interactions | CALM3 PCDHGA7 DUOX2 RPS27A ITGA4 CEP350 UBA52 UBB CTTN TIMM44 | 3.63e-05 | 331 | 123 | 10 | int:H2BC5 |
| Interaction | GSC2 interactions | 3.82e-05 | 62 | 123 | 5 | int:GSC2 | |
| Interaction | DYSF interactions | 3.82e-05 | 62 | 123 | 5 | int:DYSF | |
| Interaction | H2BC13 interactions | 4.49e-05 | 210 | 123 | 8 | int:H2BC13 | |
| Interaction | YWHAZ interactions | RAF1 DENND4A HIVEP1 CEBPB CALM1 TTC28 PPP2R2D CALM3 SPTBN2 BAG5 SYNPO ITGA4 PFKM WNK1 ADORA3 UBB NKD2 RABEP1 SNRNP40 CDK11B XRCC6 | 4.63e-05 | 1319 | 123 | 21 | int:YWHAZ |
| Interaction | TIGD1 interactions | 4.69e-05 | 12 | 123 | 3 | int:TIGD1 | |
| Interaction | H3-3A interactions | HIVEP1 SMC6 SYNPO RPS27A ITGA4 CDCA2 UBA52 UBB BAZ2A RBPJ OSBPL5 TAF1 CDK11B ASB2 XRCC6 | 5.23e-05 | 749 | 123 | 15 | int:H3-3A |
| Interaction | C11orf65 interactions | 6.07e-05 | 13 | 123 | 3 | int:C11orf65 | |
| Interaction | PLEC interactions | 6.64e-05 | 430 | 123 | 11 | int:PLEC | |
| Interaction | CAPZA2 interactions | RAF1 CALM3 SPTBN2 SYNPO IDH2 PFKM ITPR2 FGD4 TNKS1BP1 LIMCH1 CTTN | 6.64e-05 | 430 | 123 | 11 | int:CAPZA2 |
| Interaction | IQCE interactions | 7.47e-05 | 37 | 123 | 4 | int:IQCE | |
| Interaction | MYF5 interactions | 7.47e-05 | 37 | 123 | 4 | int:MYF5 | |
| Interaction | SDCBP interactions | RAF1 HIVEP1 CEBPB CALM1 CALM2 CALM3 PCDHGA7 ITGA4 IHO1 UBB UBC | 8.15e-05 | 440 | 123 | 11 | int:SDCBP |
| Interaction | UBAC1 interactions | 9.04e-05 | 119 | 123 | 6 | int:UBAC1 | |
| Interaction | H2BC9 interactions | HIVEP1 DUOX2 RPS27A ITGA4 CEP350 CDCA2 UBA52 DUOX1 UBB SETBP1 TIMM44 | 9.19e-05 | 446 | 123 | 11 | int:H2BC9 |
| Interaction | UBE2NL interactions | 9.57e-05 | 15 | 123 | 3 | int:UBE2NL | |
| Interaction | ZNF362 interactions | 1.02e-04 | 40 | 123 | 4 | int:ZNF362 | |
| Interaction | FLNB interactions | 1.05e-04 | 304 | 123 | 9 | int:FLNB | |
| Interaction | YY1 interactions | RAF1 HIVEP1 SREBF1 RPS27A CDCA2 UBA52 UBB SNRNP40 TAF1 CTTN XRCC6 | 1.08e-04 | 454 | 123 | 11 | int:YY1 |
| Interaction | HRES1 interactions | 1.10e-04 | 3 | 123 | 2 | int:HRES1 | |
| Interaction | RAD18 interactions | CALM1 SMC6 SP110 UBB UBC SLF2 SNRNP40 CCDC97 CDK11B CTTN TIMM44 | 1.14e-04 | 457 | 123 | 11 | int:RAD18 |
| Interaction | CAMK2G interactions | 1.14e-04 | 240 | 123 | 8 | int:CAMK2G | |
| Interaction | ZNF280A interactions | 1.17e-04 | 16 | 123 | 3 | int:ZNF280A | |
| Interaction | RPL23 interactions | KCTD12 FAT4 CEBPB CALM1 PCDHGA7 FAT3 BAG5 PCDHB6 RPS27A ITGA4 PCDHB16 FGR | 1.17e-04 | 540 | 123 | 12 | int:RPL23 |
| Interaction | SNCA interactions | CALM1 BAG5 APOA1 IDH2 GTF2A1 UBA52 UBB SACS SNRNP40 SYK TNKS1BP1 FGR CTTN XRCC6 | 1.21e-04 | 716 | 123 | 14 | int:SNCA |
| Interaction | ZNF774 interactions | 1.23e-04 | 79 | 123 | 5 | int:ZNF774 | |
| Interaction | CDC73 interactions | CEBPB CALM1 CALM2 CALM3 RPS27A UBA52 UBB RABEP1 CDK11B XRCC6 | 1.30e-04 | 386 | 123 | 10 | int:CDC73 |
| Interaction | HNRNPD interactions | CEBPB INTS7 SMC6 OBSCN ITGA4 DYSF WNK1 UBC SBF2 SNRNP40 ASB2 XRCC6 MAN1B1 | 1.43e-04 | 638 | 123 | 13 | int:HNRNPD |
| Interaction | ZNF451 interactions | 1.55e-04 | 83 | 123 | 5 | int:ZNF451 | |
| Interaction | KCNQ2 interactions | 1.64e-04 | 84 | 123 | 5 | int:KCNQ2 | |
| Interaction | MAP3K3 interactions | 1.64e-04 | 84 | 123 | 5 | int:MAP3K3 | |
| Interaction | XRCC6 interactions | RAF1 CEBPB RPS27A ITGA4 DYSF CDCA2 GTF2A1 RNF123 UBC BAZ2A RBPJ TAF1 CDK11B TAF1L FMNL1 XRCC6 | 1.67e-04 | 928 | 123 | 16 | int:XRCC6 |
| Interaction | CAMTA2 interactions | 1.69e-04 | 18 | 123 | 3 | int:CAMTA2 | |
| Interaction | C6 interactions | 1.69e-04 | 18 | 123 | 3 | int:C6 | |
| Interaction | MTHFR interactions | 1.77e-04 | 46 | 123 | 4 | int:MTHFR | |
| Interaction | PML interactions | CALM1 CALM2 CALM3 INTS7 SMC6 SYNPO RPS27A ITPR2 UBA52 RNF123 UBC SLF2 SNRNP40 TNKS1BP1 CTTN MAN1B1 | 1.78e-04 | 933 | 123 | 16 | int:PML |
| Interaction | RALA interactions | 1.88e-04 | 136 | 123 | 6 | int:RALA | |
| Interaction | H2BC4 interactions | 1.93e-04 | 259 | 123 | 8 | int:H2BC4 | |
| Interaction | TNS3 interactions | 1.93e-04 | 87 | 123 | 5 | int:TNS3 | |
| Interaction | DCDC1 interactions | 2.00e-04 | 19 | 123 | 3 | int:DCDC1 | |
| Interaction | FBXO2 interactions | 2.16e-04 | 411 | 123 | 10 | int:FBXO2 | |
| Interaction | H2BC17 interactions | 2.20e-04 | 140 | 123 | 6 | int:H2BC17 | |
| Interaction | ADRB2 interactions | 2.38e-04 | 339 | 123 | 9 | int:ADRB2 | |
| Interaction | TRIM15 interactions | 2.45e-04 | 50 | 123 | 4 | int:TRIM15 | |
| Interaction | RAD54B interactions | 2.45e-04 | 50 | 123 | 4 | int:RAD54B | |
| Interaction | EDF1 interactions | 2.64e-04 | 93 | 123 | 5 | int:EDF1 | |
| Interaction | IQGAP1 interactions | RAF1 CEBPB CALM1 PPP2R2D CALM2 CALM3 SPTBN2 SYNPO ITGA4 PTK2 LIMCH1 CTTN | 2.70e-04 | 591 | 123 | 12 | int:IQGAP1 |
| Interaction | H2AX interactions | FKBP10 CEBPB CALM1 CALM2 DUOX2 RPS27A TIAM2 UBA52 UBB HNRNPUL2 BAZ2A XRCC6 | 2.78e-04 | 593 | 123 | 12 | int:H2AX |
| Interaction | UBE2N interactions | 3.07e-04 | 351 | 123 | 9 | int:UBE2N | |
| Interaction | SMARCAL1 interactions | 3.07e-04 | 53 | 123 | 4 | int:SMARCAL1 | |
| Interaction | TAF1L interactions | 3.14e-04 | 22 | 123 | 3 | int:TAF1L | |
| Interaction | INVS interactions | 3.53e-04 | 99 | 123 | 5 | int:INVS | |
| Interaction | ADAMTS12 interactions | 3.54e-04 | 55 | 123 | 4 | int:ADAMTS12 | |
| Interaction | MAP6D1 interactions | 3.65e-04 | 5 | 123 | 2 | int:MAP6D1 | |
| Interaction | H2BC14 interactions | 3.70e-04 | 100 | 123 | 5 | int:H2BC14 | |
| Interaction | INF2 interactions | 3.93e-04 | 288 | 123 | 8 | int:INF2 | |
| Interaction | TAF4 interactions | 3.94e-04 | 156 | 123 | 6 | int:TAF4 | |
| Interaction | EEF1AKMT3 interactions | 4.00e-04 | 364 | 123 | 9 | int:EEF1AKMT3 | |
| Interaction | KIF1A interactions | 4.05e-04 | 102 | 123 | 5 | int:KIF1A | |
| Interaction | DNAJB2 interactions | 4.05e-04 | 102 | 123 | 5 | int:DNAJB2 | |
| Interaction | CAMK2D interactions | 4.32e-04 | 222 | 123 | 7 | int:CAMK2D | |
| Interaction | EXOSC10 interactions | 4.43e-04 | 223 | 123 | 7 | int:EXOSC10 | |
| Interaction | CCNT1 interactions | 4.68e-04 | 225 | 123 | 7 | int:CCNT1 | |
| Interaction | PTPN23 interactions | 4.82e-04 | 162 | 123 | 6 | int:PTPN23 | |
| Interaction | RCOR2 interactions | 4.95e-04 | 60 | 123 | 4 | int:RCOR2 | |
| Interaction | ITGAV interactions | 4.98e-04 | 163 | 123 | 6 | int:ITGAV | |
| Interaction | TTN interactions | 5.04e-04 | 299 | 123 | 8 | int:TTN | |
| Interaction | NXF1 interactions | RAF1 FAT4 CALM1 CALM3 OBSCN SYNPO PFKM ITPR2 CEP350 RNF123 UPF2 SNRNP40 TTL PARN CCDC97 TAF1 CTTN TAF1L XRCC6 | 5.07e-04 | 1345 | 123 | 19 | int:NXF1 |
| Interaction | CLIC1 interactions | 5.31e-04 | 165 | 123 | 6 | int:CLIC1 | |
| Interaction | JAK2 interactions | 5.31e-04 | 165 | 123 | 6 | int:JAK2 | |
| Interaction | CST9 interactions | 5.45e-04 | 6 | 123 | 2 | int:CST9 | |
| Interaction | ADAMTS9 interactions | 5.45e-04 | 6 | 123 | 2 | int:ADAMTS9 | |
| Interaction | FAM83C interactions | 5.45e-04 | 6 | 123 | 2 | int:FAM83C | |
| Interaction | RFC1 interactions | 5.47e-04 | 231 | 123 | 7 | int:RFC1 | |
| Interaction | HUNK interactions | 5.50e-04 | 109 | 123 | 5 | int:HUNK | |
| Interaction | CCNT2 interactions | 5.61e-04 | 62 | 123 | 4 | int:CCNT2 | |
| Interaction | ZNRF4 interactions | 5.73e-04 | 110 | 123 | 5 | int:ZNRF4 | |
| Interaction | ARPC5 interactions | 5.73e-04 | 110 | 123 | 5 | int:ARPC5 | |
| Interaction | GP1BA interactions | 5.83e-04 | 27 | 123 | 3 | int:GP1BA | |
| Interaction | PIK3AP1 interactions | 5.83e-04 | 27 | 123 | 3 | int:PIK3AP1 | |
| Interaction | GRAMD1A interactions | 5.84e-04 | 168 | 123 | 6 | int:GRAMD1A | |
| Cytoband | 12q24.3 | 1.10e-04 | 6 | 125 | 2 | 12q24.3 | |
| Cytoband | 5q31 | 2.87e-04 | 115 | 125 | 4 | 5q31 | |
| Cytoband | 20q13.1 | 3.26e-04 | 10 | 125 | 2 | 20q13.1 | |
| GeneFamily | EF-hand domain containing | 1.35e-05 | 219 | 90 | 8 | 863 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 9.22e-05 | 18 | 90 | 3 | 1160 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.10e-03 | 181 | 90 | 5 | 694 | |
| GeneFamily | Cadherin related | 3.17e-03 | 17 | 90 | 2 | 24 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.67e-03 | 206 | 90 | 5 | 682 | |
| GeneFamily | Clustered protocadherins | 3.99e-03 | 64 | 90 | 3 | 20 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.35e-03 | 66 | 90 | 3 | 722 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | RAF1 CALM3 SPTBN2 L1CAM APOA1 SYNPO RPS27A PFKM ITGAE PTK2 ADORA3 UBB CDH22 FGD4 GYS2 SYK PLCG2 FGR SLC27A2 BEGAIN | 2.78e-06 | 1281 | 125 | 20 | M1884 |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP | 4.07e-06 | 23 | 125 | 4 | MM694 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 9.80e-06 | 286 | 125 | 9 | M45746 | |
| Coexpression | JIANG_MELANOMA_TRM3_CD8 | 3.74e-05 | 424 | 125 | 10 | M48967 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 4.90e-05 | 199 | 125 | 7 | M9124 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | DENND4A PPP2R2D CALM2 INTS7 SREBF1 PTK2 CEP350 UBC SETBP1 RBPJ VPS35L SYK TTL MAN1B1 | 5.13e-05 | 843 | 125 | 14 | M2356 |
| Coexpression | MANALO_HYPOXIA_UP | 5.91e-05 | 205 | 125 | 7 | M259 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP | 6.86e-05 | 17 | 125 | 3 | MM686 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 6.89e-05 | 46 | 125 | 4 | MM670 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-10 | 162 | 125 | 9 | 484ea4ac40de672dcbd2583a52cb7f385c918814 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-10 | 162 | 125 | 9 | bba144ac5332bab9eba2ccf599703c781a7f88f1 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-09 | 168 | 125 | 9 | d823979335ac6b5d1f062ebb741c759d2f919dbf | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-09 | 168 | 125 | 9 | f377ff4c066a9857ad14d245e56325ad220e22e1 | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.55e-09 | 200 | 125 | 9 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-08 | 160 | 125 | 8 | bc4a93dc5f37829799c37877e751ff3bc122e4ab | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-08 | 162 | 125 | 8 | 3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-08 | 162 | 125 | 8 | 8134f73eb76693f4f1845f643042fdc1e81c274c | |
| ToppCell | facs-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-08 | 165 | 125 | 8 | 720649f330382ea2a68c64a5344160a048afb8f1 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-08 | 170 | 125 | 8 | 8e774af244cfe787fa0ea2b6be0c3c2d00bfe4fc | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-08 | 170 | 125 | 8 | f5140eb9313c0d1bb31f8a761d9c062c56733a61 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.98e-08 | 171 | 125 | 8 | 00739085fdbc4d64c9faacba2c2adeab580dd2b1 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.12e-08 | 172 | 125 | 8 | 5f58ff6cac32546d07b2a49ed250b6c7aa417188 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-08 | 175 | 125 | 8 | c8cfe0ac0c1ac447c626a623cc49692a0b177a1c | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-08 | 175 | 125 | 8 | 61fbd8f685d3daad46449e4c0386a38886496566 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-08 | 175 | 125 | 8 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.01e-08 | 191 | 125 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.60e-08 | 193 | 125 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.90e-08 | 194 | 125 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 7.90e-08 | 194 | 125 | 8 | 7b8fe5b702b99aac5bff7de8ac0b5cabb3235b56 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 8.22e-08 | 195 | 125 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.89e-08 | 197 | 125 | 8 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.25e-08 | 198 | 125 | 8 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 9.61e-08 | 199 | 125 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | COVID-19|World / group, cell type (main and fine annotations) | 9.99e-08 | 200 | 125 | 8 | ac38a468559c33ee00152735ce6e408f3f48df84 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.39e-07 | 151 | 125 | 7 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.25e-07 | 158 | 125 | 7 | 121d63b8e2e37107467b170e5b2c798a7dbf6325 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.01e-07 | 163 | 125 | 7 | bbbc3f0ce2616d07136f69ce682ba1d3790711d9 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.92e-07 | 168 | 125 | 7 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.92e-07 | 168 | 125 | 7 | c0aef5947b1d7e2c81a7481c509feda1687fcd7f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.92e-07 | 168 | 125 | 7 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-07 | 169 | 125 | 7 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-07 | 169 | 125 | 7 | 411556e93adcbb7e4d79b02f3dc72963ec8a0759 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-07 | 169 | 125 | 7 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-07 | 169 | 125 | 7 | 39b1acfd099abb9de18c29c05c7a67709ea76775 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-07 | 172 | 125 | 7 | 51bea97564a33f0060c546c9be4bf8bf8f1660f6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-07 | 172 | 125 | 7 | be4dd4ba8d7a651677c797c25fd75f14e627415a | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-07 | 173 | 125 | 7 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.53e-07 | 179 | 125 | 7 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.06e-07 | 184 | 125 | 7 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.06e-07 | 184 | 125 | 7 | c451acfcd8fe28c1f4b1ea334b1129fa84a15c42 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-07 | 185 | 125 | 7 | 4e40d3103ebf4a7066b7ce300b6ef700ba0e2863 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-07 | 186 | 125 | 7 | 16092819e9148dfe64f07c737652b6e533e699f7 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.01e-06 | 187 | 125 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.01e-06 | 187 | 125 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | facs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 189 | 125 | 7 | 7ce71f9c81512ed38c804f025908746b4af3aab1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.20e-06 | 192 | 125 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.25e-06 | 193 | 125 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-06 | 193 | 125 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.29e-06 | 194 | 125 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.29e-06 | 194 | 125 | 7 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-06 | 194 | 125 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 1.34e-06 | 195 | 125 | 7 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-06 | 195 | 125 | 7 | 279530c54eb1ada0297c64e12b33f9ffc3975c1e | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-06 | 195 | 125 | 7 | 7bde23821909a692d0bac4d01ee825ba2f95c0a0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.34e-06 | 195 | 125 | 7 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-06 | 195 | 125 | 7 | 145865d0a4e19435f3dcbfd626cbd25be17f92fb | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.34e-06 | 195 | 125 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-06 | 195 | 125 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-06 | 195 | 125 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.34e-06 | 195 | 125 | 7 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.38e-06 | 196 | 125 | 7 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 1.38e-06 | 196 | 125 | 7 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.38e-06 | 196 | 125 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.38e-06 | 196 | 125 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-06 | 197 | 125 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | PCW_10-12|World / Celltypes from embryonic and fetal-stage human lung | 1.43e-06 | 197 | 125 | 7 | 47fd8b0d596c5db1a722473c8efbb17a6bbe7538 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.43e-06 | 197 | 125 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.48e-06 | 198 | 125 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.48e-06 | 198 | 125 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.48e-06 | 198 | 125 | 7 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.53e-06 | 199 | 125 | 7 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-intermediate_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.53e-06 | 199 | 125 | 7 | f9e3fb974ba8fe1b6d99892577549ef143df9e08 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.53e-06 | 199 | 125 | 7 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-06 | 200 | 125 | 7 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-06 | 200 | 125 | 7 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.58e-06 | 200 | 125 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.58e-06 | 200 | 125 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-06 | 200 | 125 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-Neurons|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.58e-06 | 200 | 125 | 7 | ddac952ad1d46021c2d17d816de9bc31730a0941 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-06 | 200 | 125 | 7 | cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.58e-06 | 200 | 125 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.32e-06 | 144 | 125 | 6 | 7de962346ba9653d90dd13bb7d977fe44d200bba | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-06 | 153 | 125 | 6 | 6dcab3d50ab50051955204dc4e4a64c1ca855bcd | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-06 | 153 | 125 | 6 | f6ef14d949107c08cb3690e26ec91e194cb43518 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.08e-06 | 155 | 125 | 6 | cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.46e-06 | 157 | 125 | 6 | 904cd98ae85ed6459e0663f077ac462842bf12df | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-06 | 159 | 125 | 6 | f7803f7b4e0379ae8256ec53110833bedee7db98 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-06 | 159 | 125 | 6 | 6e2d38e78d2ef7803e8bb154b5c788bf62a41045 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-06 | 160 | 125 | 6 | 2020b6defbaf5b5db12af37f0103ac028a8ca76e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-06 | 160 | 125 | 6 | af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-06 | 163 | 125 | 6 | 04152557aae230e9587fcc16cbabf1247cc5b419 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-06 | 163 | 125 | 6 | 0644eb8a66d4e944063125c423de66d2393388b1 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 164 | 125 | 6 | 1250876abd7311f86730e5b9c03c3610cc2ff6d3 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 164 | 125 | 6 | fa0d77b648cde5e42b9394e877168c80de238bde | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.02e-06 | 164 | 125 | 6 | 11dfd84f5fb90de330858e1e852848832734e004 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-06 | 166 | 125 | 6 | e01c720de6d4ca144c55378e023e718a64bf32f6 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.05e-06 | 168 | 125 | 6 | c861f80aa12caf54a94d93e38539ff41dc5227a6 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.33e-06 | 169 | 125 | 6 | b059304543876f514d5c7214f1f0a2da00f10a67 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-non-classical_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.33e-06 | 169 | 125 | 6 | 945f737984c4de70a4e9c214053b005358053dd5 | |
| Drug | AC1L1KMJ | RAF1 COL5A1 COL11A1 CALM1 CALM2 CALM3 SPTBN2 ITGA4 PTK2 SACS CD47 SYK PAM PLCG2 CTTN ALPP | 6.31e-09 | 476 | 123 | 16 | CID000030956 |
| Drug | KHL-8430 | 2.80e-08 | 7 | 123 | 4 | CID000195711 | |
| Drug | 2c5o | RAF1 CALM1 CALM2 CALM3 POLE RPS27A UBA52 UBB UBC TAF1 CDK11B FGR | 4.73e-08 | 284 | 123 | 12 | CID000447956 |
| Drug | NSC366363 | 1.54e-07 | 3 | 123 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 1.54e-07 | 3 | 123 | 3 | CID004630710 | |
| Drug | tatsiensine | 1.54e-07 | 3 | 123 | 3 | CID000163526 | |
| Drug | delcosine | 1.54e-07 | 3 | 123 | 3 | CID000120726 | |
| Drug | 1-isoamyl-3-isobutylxanthine | 1.66e-07 | 10 | 123 | 4 | CID000152034 | |
| Drug | Ins(1,3)P2 | 2.60e-07 | 11 | 123 | 4 | CID000128419 | |
| Drug | N,N'-disalicylidene-1,3-diaminopropane | 5.42e-07 | 30 | 123 | 5 | CID005373003 | |
| Drug | Shikoccin | 6.13e-07 | 4 | 123 | 3 | CID000327536 | |
| Drug | Nsc642900 | 6.13e-07 | 4 | 123 | 3 | CID000498959 | |
| Drug | CTK0F9956 | 6.13e-07 | 4 | 123 | 3 | CID011779542 | |
| Drug | 85318-25-8 | 6.13e-07 | 4 | 123 | 3 | CID006439702 | |
| Drug | cloxacepride | 6.13e-07 | 4 | 123 | 3 | CID000068859 | |
| Drug | chloraniformethan | 6.13e-07 | 4 | 123 | 3 | CID000030331 | |
| Drug | Ti 233 | 6.13e-07 | 4 | 123 | 3 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 6.13e-07 | 4 | 123 | 3 | CID000080867 | |
| Drug | Ula 1 | 6.13e-07 | 4 | 123 | 3 | CID003047135 | |
| Drug | herbarumin III | 6.13e-07 | 4 | 123 | 3 | CID000643678 | |
| Drug | thiomethylpromazine | 6.13e-07 | 4 | 123 | 3 | CID000070583 | |
| Drug | uranium-bromide | 6.13e-07 | 4 | 123 | 3 | CID000083507 | |
| Drug | KS-504e | 6.13e-07 | 4 | 123 | 3 | CID000129559 | |
| Drug | KS-504d | 6.13e-07 | 4 | 123 | 3 | CID000129557 | |
| Drug | Archanagelicine | 6.13e-07 | 4 | 123 | 3 | CID003083773 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 6.13e-07 | 4 | 123 | 3 | CID000127194 | |
| Drug | Roylin | 6.13e-07 | 4 | 123 | 3 | CID000099924 | |
| Drug | KS-502 | 6.13e-07 | 4 | 123 | 3 | CID000129242 | |
| Drug | KS-501 | 6.13e-07 | 4 | 123 | 3 | CID000129240 | |
| Drug | 2'-methoxykobusin | 6.13e-07 | 4 | 123 | 3 | CID000637889 | |
| Drug | PS-990 | 6.13e-07 | 4 | 123 | 3 | CID000157810 | |
| Drug | PDE II | 7.29e-07 | 93 | 123 | 7 | CID003047060 | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A | KCTD12 INTS7 L1CAM ITGA8 SP110 ITPR2 HNRNPUL2 RABEP1 CACNA1I | 1.22e-06 | 196 | 123 | 9 | 3896_UP |
| Drug | jujubogenin | 1.53e-06 | 5 | 123 | 3 | CID005318721 | |
| Drug | D 890 | 1.53e-06 | 5 | 123 | 3 | CID000134083 | |
| Drug | NSC-36360 | 1.53e-06 | 5 | 123 | 3 | CID000133340 | |
| Drug | Papet | 1.53e-06 | 5 | 123 | 3 | CID005310950 | |
| Drug | 4-(oxyacetyl)phenoxyacetic acid | 1.53e-06 | 5 | 123 | 3 | CID000170173 | |
| Drug | alpha-CAO | 1.53e-06 | 5 | 123 | 3 | CID000196600 | |
| Drug | AC1NS8P3 | 1.53e-06 | 5 | 123 | 3 | CID005356151 | |
| Drug | 4H-1,4-benzothiazin-3-one | 1.53e-06 | 5 | 123 | 3 | CID000021396 | |
| Drug | Y-acid | 1.53e-06 | 5 | 123 | 3 | CID000007022 | |
| Drug | C16AA | 1.53e-06 | 5 | 123 | 3 | CID000488017 | |
| Drug | auranthine | 1.53e-06 | 5 | 123 | 3 | CID000130919 | |
| Drug | Ant-ATP | 1.53e-06 | 5 | 123 | 3 | CID000134953 | |
| Drug | Nor2 chlorpromazine | 1.53e-06 | 5 | 123 | 3 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 1.53e-06 | 5 | 123 | 3 | CID005748474 | |
| Drug | Ac-dvda | 1.53e-06 | 5 | 123 | 3 | CID000146768 | |
| Drug | VUF 4576 | 1.53e-06 | 5 | 123 | 3 | CID000132784 | |
| Drug | wartmannin | RAF1 CALM1 CALM2 CALM3 SREBF1 ITGA4 PTK2 ADORA3 UPF2 FGD4 GYS2 SBF2 CD47 SYK SMPD2 PLCG2 XRCC6 | 1.76e-06 | 811 | 123 | 17 | CID000005691 |
| Drug | Org 9935 | 1.83e-06 | 17 | 123 | 4 | CID000131100 | |
| Drug | Pkcs | 2.25e-06 | 211 | 123 | 9 | CID000164073 | |
| Drug | 1H-imidazole hydrochloride | 2.34e-06 | 18 | 123 | 4 | CID000518985 | |
| Drug | AC1NDTNH | COL5A1 COL11A1 POLE UBC UPF2 HNRNPUL2 RBPJ TAF1 PLCG2 TAF1L XRCC6 | 2.65e-06 | 343 | 123 | 11 | CID004631409 |
| Drug | AC1NSV6X | 3.04e-06 | 6 | 123 | 3 | CID005317173 | |
| Drug | N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 3.04e-06 | 6 | 123 | 3 | CID000004307 | |
| Drug | 2,5-diketocamphane | 3.04e-06 | 6 | 123 | 3 | CID000020218 | |
| Drug | benziodarone | 3.04e-06 | 6 | 123 | 3 | CID000006237 | |
| Drug | AC1LCMSV | 3.04e-06 | 6 | 123 | 3 | CID000633347 | |
| Drug | CI-922 | 3.04e-06 | 6 | 123 | 3 | CID000146938 | |
| Drug | caged PE | 3.04e-06 | 6 | 123 | 3 | CID000192405 | |
| Drug | propyl-methylenedioxyindene | 3.04e-06 | 6 | 123 | 3 | CID000145934 | |
| Drug | AC1L1HZ7 | 3.07e-06 | 42 | 123 | 5 | CID000004355 | |
| Drug | AC1L1G9T | RAF1 CEBPB CALM1 CALM2 CALM3 ITGA4 PTK2 SYK SMPD2 PLCG2 FGR CTTN | 4.12e-06 | 433 | 123 | 12 | CID000003591 |
| Drug | benzophenone-4-maleimide | 4.36e-06 | 45 | 123 | 5 | CID000146390 | |
| Drug | Frenolon | 4.52e-06 | 21 | 123 | 4 | CID000009800 | |
| Drug | Leu-ala | 4.87e-06 | 46 | 123 | 5 | CID000081721 | |
| Drug | 1-(4-pyridyl)ethanol | 5.30e-06 | 7 | 123 | 3 | CID000090919 | |
| Drug | AC1L52O2 | 5.30e-06 | 7 | 123 | 3 | CID000196983 | |
| Drug | chloronitromethane | 5.30e-06 | 7 | 123 | 3 | CID000074529 | |
| Drug | trifluoperazine sulfoxide | 5.30e-06 | 7 | 123 | 3 | CID000159622 | |
| Drug | DyCl3 | 5.30e-06 | 7 | 123 | 3 | CID000066207 | |
| Drug | DAPpNP | 5.30e-06 | 7 | 123 | 3 | CID005492375 | |
| Drug | T 7188 | 5.30e-06 | 7 | 123 | 3 | CID000003311 | |
| Drug | MS-857 | 5.30e-06 | 7 | 123 | 3 | CID000129517 | |
| Drug | SQ 65442 | 5.30e-06 | 7 | 123 | 3 | CID000128039 | |
| Drug | AC1L3PE4 | 5.30e-06 | 7 | 123 | 3 | CID000093048 | |
| Drug | O-4-(ethoxybutyl)berbamine | 5.30e-06 | 7 | 123 | 3 | CID000188375 | |
| Drug | TZC-5665 | 5.30e-06 | 7 | 123 | 3 | CID006449836 | |
| Drug | CPU57 | 5.30e-06 | 7 | 123 | 3 | CID000195730 | |
| Drug | Drnflrfamide | 5.30e-06 | 7 | 123 | 3 | CID000132879 | |
| Drug | L2-G | 5.30e-06 | 7 | 123 | 3 | CID009549184 | |
| Drug | 4-hydroxyphenylglycol | 5.30e-06 | 7 | 123 | 3 | CID003081980 | |
| Drug | asocainol | 5.30e-06 | 7 | 123 | 3 | CID000071161 | |
| Drug | N,N-dimethyl-D-erythro-sphingosine | 5.91e-06 | 83 | 123 | 6 | CID000004285 | |
| Drug | NHS-LC-biotin | 6.63e-06 | 23 | 123 | 4 | CID000083874 | |
| Drug | AC1NDK7X | 7.77e-06 | 87 | 123 | 6 | CID004627201 | |
| Drug | denbufylline | 7.93e-06 | 24 | 123 | 4 | CID000002984 | |
| Drug | proxyl nitroxide | 8.45e-06 | 8 | 123 | 3 | CID000076702 | |
| Drug | niludipine | 8.45e-06 | 8 | 123 | 3 | CID000089767 | |
| Drug | Ro 22-4839 | 8.45e-06 | 8 | 123 | 3 | CID000065839 | |
| Drug | HT-74 | 8.45e-06 | 8 | 123 | 3 | CID000126681 | |
| Drug | 2,6-ANS | 8.45e-06 | 8 | 123 | 3 | CID002762570 | |
| Drug | AC1MJ4D0 | 8.45e-06 | 8 | 123 | 3 | CID003085362 | |
| Drug | 3,7,8-trihydroxy-CPZ | 8.45e-06 | 8 | 123 | 3 | CID000467415 | |
| Drug | KS-504a | 8.45e-06 | 8 | 123 | 3 | CID000129577 | |
| Drug | NSP-805 | 8.45e-06 | 8 | 123 | 3 | CID000130349 | |
| Drug | hydroxamates | 9.40e-06 | 25 | 123 | 4 | CID000033630 | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; PC3; HT_HG-U133A | 1.16e-05 | 196 | 123 | 8 | 4331_UP | |
| Drug | AC1L1O6Q | 1.17e-05 | 141 | 123 | 7 | CID000058035 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 7.52e-06 | 10 | 119 | 3 | C1631597 | |
| Disease | waist-hip ratio | PAPPA2 COL5A1 CPAMD8 COL11A1 CEBPB TTC28 WNK1 LACTBL1 CDCA2 RNF123 ADAMTS9 SBF2 SETBP1 RBPJ PAM LRRC36 | 3.44e-05 | 1226 | 119 | 16 | EFO_0004343 |
| Disease | Romano-Ward Syndrome | 3.45e-05 | 16 | 119 | 3 | C0035828 | |
| Disease | neutrophil count | PAPPA2 CPAMD8 DENND4A COL11A1 HIVEP1 TTC28 PPP2R2D BAG5 EML6 ITGA4 ITPR2 GTF2A1 RABEP1 SBF2 RBPJ IQSEC1 PAM | 4.03e-05 | 1382 | 119 | 17 | EFO_0004833 |
| Disease | phenylketonuria (implicated_via_orthology) | 9.63e-05 | 4 | 119 | 2 | DOID:9281 (implicated_via_orthology) | |
| Disease | pack-years measurement, Barrett's esophagus | 1.60e-04 | 5 | 119 | 2 | EFO_0000280, EFO_0006526 | |
| Disease | Phencyclidine-Related Disorders | 3.34e-04 | 7 | 119 | 2 | C0236742 | |
| Disease | Phencyclidine Abuse | 3.34e-04 | 7 | 119 | 2 | C0031391 | |
| Disease | retinal detachment, retinal break | 3.81e-04 | 35 | 119 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | Colorectal Carcinoma | CPAMD8 POLE FSTL5 SPTBN2 OBSCN WNK1 ADORA3 CDH22 SACS SETBP1 | 5.66e-04 | 702 | 119 | 10 | C0009402 |
| Disease | Inherited neuropathies | 5.67e-04 | 40 | 119 | 3 | C0598589 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 5.70e-04 | 9 | 119 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | APOE carrier status, cerebral amyloid angiopathy | 6.55e-04 | 42 | 119 | 3 | EFO_0006790, EFO_0007659 | |
| Disease | Cannabis Abuse | 7.11e-04 | 10 | 119 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 7.11e-04 | 10 | 119 | 2 | C0236735 | |
| Disease | Hashish Abuse | 7.11e-04 | 10 | 119 | 2 | C0018614 | |
| Disease | nephritis (implicated_via_orthology) | 7.11e-04 | 10 | 119 | 2 | DOID:10952 (implicated_via_orthology) | |
| Disease | high grade glioma (implicated_via_orthology) | 7.51e-04 | 44 | 119 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 7.82e-04 | 268 | 119 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | mean platelet volume | TTC28 PCDHGA7 EML6 ANKRD46 BAZ2A FGD4 RABEP1 GYS2 SETBP1 SYK TTC13 PLCG2 | 8.71e-04 | 1020 | 119 | 12 | EFO_0004584 |
| Disease | overall survival, pancreatic carcinoma | 1.03e-03 | 49 | 119 | 3 | EFO_0000638, EFO_0002618 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.04e-03 | 12 | 119 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease type 4 | 1.22e-03 | 13 | 119 | 2 | cv:C4082197 | |
| Disease | hypothyroidism (implicated_via_orthology) | 1.22e-03 | 13 | 119 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | electrocardiography | 1.41e-03 | 530 | 119 | 8 | EFO_0004327 | |
| Disease | anti-basement membrane glomerulonephritis (implicated_via_orthology) | 1.42e-03 | 14 | 119 | 2 | DOID:4780 (implicated_via_orthology) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 1.42e-03 | 14 | 119 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | trimethylamine-N-oxide measurement | 1.42e-03 | 14 | 119 | 2 | EFO_0010541 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 1.42e-03 | 14 | 119 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | Chronic Lymphocytic Leukemia | 1.44e-03 | 55 | 119 | 3 | C0023434 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.52e-03 | 206 | 119 | 5 | C0152013 | |
| Disease | Hypertrophic Cardiomyopathy | 1.60e-03 | 57 | 119 | 3 | C0007194 | |
| Disease | hepcidin:transferrin saturation ratio | 1.64e-03 | 15 | 119 | 2 | EFO_0007902 | |
| Disease | lung small cell carcinoma (is_marker_for) | 1.87e-03 | 16 | 119 | 2 | DOID:5409 (is_marker_for) | |
| Disease | cognitive function measurement | COL5A1 DENND4A COL11A1 HIVEP1 TTC28 PPP2R2D BAG5 FPGT PTK2 FGD4 SETBP1 CD47 CACNA1I CPNE7 | 1.93e-03 | 1434 | 119 | 14 | EFO_0008354 |
| Disease | Cannabis Dependence | 2.11e-03 | 17 | 119 | 2 | C0006870 | |
| Disease | non-alcoholic steatohepatitis (biomarker_via_orthology) | 2.11e-03 | 17 | 119 | 2 | DOID:0080547 (biomarker_via_orthology) | |
| Disease | Dyschondroplasias | 2.64e-03 | 19 | 119 | 2 | C0013366 | |
| Disease | unipolar depression, bipolar disorder | 3.73e-03 | 156 | 119 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | Renal glomerular disease | 3.86e-03 | 23 | 119 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 3.86e-03 | 23 | 119 | 2 | C4521256 | |
| Disease | peripheral neuropathy, response to antimicrotubule agent | 3.86e-03 | 23 | 119 | 2 | EFO_0003100, EFO_0005260 | |
| Disease | schizophrenia (is_implicated_in) | 3.90e-03 | 78 | 119 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | erythrocyte measurement | 3.93e-03 | 257 | 119 | 5 | EFO_0005047 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSSGIGREGAKDSYD | 461 | Q9H2A2 | |
| GEVLSFDGNRTDKNY | 381 | Q9UL15 | |
| RVFDKDGNGYISAAE | 91 | P0DP25 | |
| EKLFSFLRGYLSGQS | 71 | Q96LK0 | |
| NLSNSKETGAFYGRE | 211 | P0DMS8 | |
| EESREGGQKSFLYSE | 291 | Q5JQC9 | |
| YKADSFSEGDDLSQG | 471 | Q9BUH8 | |
| SGQLEALRFLAKYGA | 281 | Q96Q27 | |
| KSGYSLNFSEGDGRR | 1746 | Q9UIF9 | |
| LFIAGRYEFSNKGAD | 326 | P54840 | |
| DDDRGSNSKLSYVLF | 2286 | Q6V0I7 | |
| SNSKLSYVLFGGNED | 2291 | Q6V0I7 | |
| EFNYSGDLLATGDKG | 41 | Q66LE6 | |
| DQGDFYSLLSKLLGE | 386 | P19021 | |
| LKDSGRDYVSQFEGS | 46 | P02647 | |
| GYSQLGDDDLKETGF | 761 | P21127 | |
| IDGDFNYSKRLLESG | 21 | Q86W74 | |
| KFGADLLATDYQGNT | 66 | Q86W74 | |
| RVFDKDGNGYISAAE | 91 | P0DP24 | |
| DLAINDYDFNSGKRL | 541 | Q7Z401 | |
| FGYQRRASDDGKLTD | 36 | P04049 | |
| IALFYLQDRDSGKNG | 366 | Q9Y5G6 | |
| YKAKSAGNLDESDFG | 426 | Q15276 | |
| DRTKNDGFSSYLDED | 91 | Q5VW38 | |
| TKSFLADAGYGEQEL | 6 | Q9NVH2 | |
| SSYFERLSKFQDGGN | 901 | Q14571 | |
| YGRRAAGSFFEDLSK | 166 | A8MYP8 | |
| YDEKRSQANGAGALS | 146 | O95453 | |
| LADKDGNGYLSFREF | 826 | Q9NRD9 | |
| LGSSEKEFFYDADSG | 66 | Q9NSA2 | |
| KEDAGLEGDFRSYGA | 16 | P09769 | |
| DENRSFEGTLYKRGA | 1741 | Q86WG5 | |
| AGKNLLYDLGFDSSD | 576 | Q8IYA8 | |
| SDFGLSKALRADENY | 511 | P43405 | |
| CLDDSYASGEGLKRS | 906 | Q6DN90 | |
| ADKDGNGYLSFREFL | 831 | Q9NRD8 | |
| QRFLDGKDGDFDYST | 291 | Q96F63 | |
| GSYDKALRFLGSNDE | 1726 | P12107 | |
| GEISFNKSLYEGLNA | 1091 | P38570 | |
| REGYQVSFLDNKSSG | 271 | Q1X8D7 | |
| FNLYSEEGKGIFDSR | 641 | P08237 | |
| RFEGGSSLSNYSDLK | 26 | Q96M96 | |
| EFSYGFDGRGLKAEN | 331 | Q1KMD3 | |
| DGRDLQELGDSDKYF | 556 | P32004 | |
| YRSLESDNEEKAFGS | 1176 | P32004 | |
| YAVFNEDGSLAELKG | 956 | Q07864 | |
| DGAFLIRKREGSDSY | 666 | P16885 | |
| AGKQLEDGRTLSDYN | 46 | P62987 | |
| ASAYASGRKGAEEAE | 26 | Q969F2 | |
| GFTLRGDSDIDKNDY | 451 | P53708 | |
| SGDSLFLRKAEDFGN | 346 | Q9UKM7 | |
| DINDFGDDGSLYITK | 296 | Q8N475 | |
| KDSGTIYFEAGDQRA | 3071 | Q5VST9 | |
| AEELNGYSRKKGGFS | 116 | P83859 | |
| YLETRDFKGSEEGNT | 201 | O60906 | |
| DDYSQGGTRLDGKNL | 241 | P05187 | |
| ARDLDGGANGKISYT | 266 | Q9NRJ7 | |
| AYLGNQRSKESLGEA | 146 | Q9BXP8 | |
| DDDNYLALSSSKGEF | 791 | Q9P2N4 | |
| GTFEDGKKFDSSYDR | 71 | Q96AY3 | |
| GDQYKATDFVADRAG | 176 | P48735 | |
| RKDGDLDGYAATFSL | 316 | A8MY62 | |
| SKDDVYDFGAGRQDL | 296 | Q9P0X4 | |
| DFLSDLFSDDYGGKN | 116 | P17676 | |
| RNSDTDDGTGIYFEK | 3226 | Q8N3K9 | |
| KRQDGSYSAFGERDA | 1191 | Q8IZJ3 | |
| DYDSDKRFSALGFGA | 426 | Q9UBL6 | |
| GDGKDFYRLSGNVLS | 171 | P10643 | |
| VNDYNGRFEIDKASG | 976 | Q8TDW7 | |
| YGKGFEDKLDRGTST | 1076 | Q5VT06 | |
| ATGSYDKALRFLGSN | 1756 | P20908 | |
| TNLVGSDKYAARFGE | 356 | P13612 | |
| RLGSGYFSSNGKLEE | 611 | Q69YH5 | |
| SKRGAAYGFRLQSLD | 851 | O95466 | |
| SLKQSSEGYGLGDRA | 556 | Q9ULL0 | |
| RVFDKDGNGYISAAE | 91 | P0DP23 | |
| SALRSLYDFGELKGG | 686 | Q9UJ99 | |
| LDSKYLQTNDGAGER | 461 | Q6ZMW3 | |
| KGRDIYTFDGALNKS | 61 | Q08722 | |
| EREDADNSSFLGKIY | 4211 | Q9NZJ4 | |
| EGLSDFCNTFKLYRG | 1516 | O75923 | |
| GSYTIGRDAQADAKF | 216 | Q96CX2 | |
| FAGGDIADLKLDSDY | 266 | O14772 | |
| GRSFGDKDFRTGLEN | 36 | Q9UPQ0 | |
| LDTCGQYFDRGSSKR | 926 | Q9HAU5 | |
| RDLDAGSFGKVSYAL | 266 | Q9Y5E3 | |
| DGKATLTFLNRAEDY | 516 | Q9H0X9 | |
| NLAVLSYEGGDFEKA | 1266 | Q7Z494 | |
| NLSEASGKGAELYAR | 716 | Q8N3V7 | |
| RDVFKKGDLYFNSGD | 451 | O14975 | |
| EDGSGFDYGFKLRKT | 376 | Q8IZX4 | |
| QRLKDAGYGEKSFFA | 896 | P21675 | |
| SNDCVKLGDFGLSRY | 556 | Q05397 | |
| DGSKIAAGSADRFVY | 296 | Q96DI7 | |
| FGKNYSELRDSDSGL | 861 | Q14524 | |
| EADGADGRQRSYSSK | 641 | Q9BVL4 | |
| GARALAYGEKNLTFE | 391 | Q9HAT2 | |
| KLRGDFDSDEESLGY | 596 | Q8IX21 | |
| GKIFNQYTLDLRDSG | 751 | Q8IX21 | |
| YKASDFGQVGLDLEA | 651 | Q9HB58 | |
| SADGDKEFSDALGYL | 826 | P36956 | |
| NGRDYIFSKAIGDAE | 361 | P52655 | |
| EENLEASGDYKYSGR | 21 | P12956 | |
| KSLGQAYRELGNFEA | 321 | Q8NBP0 | |
| NDSLYGGDSKFLAEN | 846 | Q7Z3J2 | |
| RSKEGSDYFDSRSDG | 401 | Q8IVF5 | |
| DSNYLDTLSREKFAG | 431 | Q96PX8 | |
| RRGSLGFYKDAKAAS | 2251 | O15020 | |
| ADRVDKSAVGFDYQG | 166 | Q14247 | |
| LLDNKDDNGGEASRY | 511 | Q5XPI4 | |
| DDNGGEASRYIFLTK | 516 | Q5XPI4 | |
| RSGACGKNLDDTAYL | 121 | Q96SQ5 | |
| EFGKRDSLGTYSSRD | 866 | Q9C0C2 | |
| IYSNGDKEDGRFTAQ | 71 | A0A075B6T6 | |
| RSGACGKNLDDTAYL | 121 | Q8TAU3 | |
| RGDDAFKASVYGNSI | 126 | Q96SB8 | |
| NTDGGYLFIGLNEDK | 231 | Q8IYM2 | |
| GKYTSANEDLSNFGL | 156 | Q9NZM6 | |
| ADSFKVSYQLADGGE | 271 | Q16473 | |
| AGKQLEDGRTLSDYN | 46 | P0CG47 | |
| FAGKQLEDGRTLSDY | 121 | P0CG47 | |
| FYGNSDDIGVFLSKR | 146 | Q06330 | |
| YSSGNRKGFLSGLLD | 51 | O43615 | |
| GSAFFSKGNYREALT | 281 | Q96AY4 | |
| LESLQGKDDYGFSGS | 1206 | Q9H4A3 | |
| AGKQLEDGRTLSDYN | 46 | P0CG48 | |
| FAGKQLEDGRTLSDY | 121 | P0CG48 | |
| AGKQLEDGRTLSDYN | 426 | P0CG48 | |
| FAGKQLEDGRTLSDY | 501 | P0CG48 | |
| AFDNTEGKREGYSAD | 361 | Q9Y6X0 | |
| AGKQLEDGRTLSDYN | 46 | P62979 | |
| FLASYNRKKEDGEGN | 131 | Q8NG68 | |
| SSASFKREGEGKYRA | 281 | Q96PF2 | |
| IALASGQSEYGFAEK | 106 | Q6BDS2 | |
| LRGSQSFDDKIGAFY | 861 | P15822 | |
| RINKLGSGSDFEAYF | 501 | Q9Y3Q0 |